The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Satya Vani Nannapaneni
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Smt. Satya Vani Nannapaneni, a member of the promoter group of Natco Pharma, sold 17,149 equity shares in the open market between September 8 and September 10, 2025. The shares were sold on NSE and BSE for an aggregate consideration of approximately Rs. 1.45 crore. Her holding in the company reduced from 4,20,000 shares (0.23% of paid-up capital) to 4,02,851 shares (0.22%). The total share capital of Natco Pharma remained unchanged at 17,91,09,870 equity shares of Rs. 2 each.
The sale is tiny at just 0.01% of share capital and is unlikely to materially affect the stock price or investor sentiment. It is a routine regulatory disclosure by a promoter group member and does not signal any meaningful change in promoter control.